Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Efavirenz versus nevirapine in current clinical practice: A prospective, open-label observational study

Article Abstract:

An open-label, observational, prospective 18-month survey is conducted to compare the efficacy and tolerability of efavirenz and nevirapine, the two-nonnucleoside reverse transcriptase inhibitors (NNRTIs) in all-possible indication available in current clinical practice. A limited virologic and immunologic advantage of efavirenz was observed in the first 12-month assessment of antiretroviral-naive patients, whereas all other examined situations did not disclose relevant efficacy differences.

Author: Manfredi, Roberto, Calza, Leonardo, Chiodo, Francesco
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2004
United States

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Effectiveness of generic fixed-dose combinations of highly active antiretroviral therapy for treatment of HIV infection in India

Article Abstract:

The clinical and immunologic effectiveness and acute toxicity to nevirapine (NVP)-based fixed-dose combinations (FDCs) in antiretroviral-native HIV-1 infected patients in India is studied. Fixed-dose formulations of NVP-based combination therapy are safe and produced durable clinical and immunologic benefit.

Author: Pujari, Sanjay N., Naik, Eknath, Patel, Jagdish K., Mane, Abhay A., Bhagat, Shobha, Patel, Atul K., Patel, Ketan K., Dravid, Ameet
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2004
India, Analysis, Complications and side effects, HIV infection, Drug therapy, HIV infections, Highly active antiretroviral therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphism

Article Abstract:

The impact of the CYP2B6-G516T gene polymorphism on plasma concentrations of efavirenz (EFV) in HIV-1-infected children is investigated. It is found that CYP2B6-G516T polymorphisms significantly affect the median oral clearance rate of EFV in children.

Author: Fenton, Terrence, Fletcher, Courtney V., Spector, Stephen A., Saitoh, Akihiko, Brundage, Richard, Alvero, Carmelita, Hsia, Karen
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2007
Science & research, Research, Genetic polymorphisms, Clinical report, Efavirenz

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, Evaluation, HIV patients, Dosage and administration, Nevirapine
Similar abstracts:
  • Abstracts: Risk factors associated with uterine rupture during trial of labor after cesarean delivery: a case-control study
  • Abstracts: The fetal central venous pressure waveform in normal pregnancy and in umbilical placental insufficiency. Microvascular endothelial cell activation is present in the umbilical placental microcirculation in fetal placental vascular disease
  • Abstracts: Renal cell carcinoma. Surgical vs nonoperative treatment for lumber disk herniation: The Spine Patient Outcome Research Trial (SPORT) observational cohort
  • Abstracts: Interview with a leader. Support systems: With your key people in place, realizing your weight-loss goals is a done deal
  • Abstracts: Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.